You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Transdermal Patch Drug Delivery System Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application

Transdermal patches drug delivery system are a method of delivering drugs directly through the skin into the bloodstream.It mainly has polymer matrix, drug, penetration accelerator and adhesive layer.Patches can provide controlled, continuous administration of drugs that are easy to eat with minimal side effects and non-invasive.Compared to injectable and oral systems, it avoids first-pass metabolism and is easy to maintain drug concentration, ensuring that drugs reach the body with minimal side effects, ensuring good adhesion and effective release through the skin in the form of skin circulation for hours or days.
Market Analysis and Insights: Global Transdermal Patch Drug Delivery System Market
The global Transdermal Patch Drug Delivery System market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Transdermal Patch Drug Delivery System Scope and Segment
The global Transdermal Patch Drug Delivery System market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Patch Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Shunt Way
Intercellular Lipid Structure Pathway
Trans-cellular Pathway
By the application, this report covers the following segments
Hospital
Clinic
Home Care
Other
Competitive Landscape:
The Transdermal Patch Drug Delivery System key manufacturers in this market include:
Hisamitsu Pharmaceutical
Novartis
ProSolus
Tapemark
Tesa Labtec
NITTO DENKO CORPORATION
Noven Pharmaceuticals
LTS Lohmann Therapie-Systeme
Medherant
Corium
Antares Pharma
Syntropharma
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
1 Market Overview of Transdermal Patch Drug Delivery System
1.1 Transdermal Patch Drug Delivery System Market Overview
1.1.1 Transdermal Patch Drug Delivery System Product Scope
1.1.2 Market Status and Outlook
1.2 Global Transdermal Patch Drug Delivery System Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Transdermal Patch Drug Delivery System Market Size by Region (2015-2026)
1.4 Global Transdermal Patch Drug Delivery System Historic Market Size by Region (2015-2020)
1.5 Global Transdermal Patch Drug Delivery System Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2026)
1.6.1 North America Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2026)
1.6.2 Europe Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2026)
1.6.3 China Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2026)
1.6.5 Latin America Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Transdermal Patch Drug Delivery System Market Size YoY Growth (2015-2026)

2 Transdermal Patch Drug Delivery System Market Overview by Type
2.1 Global Transdermal Patch Drug Delivery System Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Transdermal Patch Drug Delivery System Historic Market Size by Type (2015-2020)
2.3 Global Transdermal Patch Drug Delivery System Forecasted Market Size by Type (2021-2026)
2.4 Shunt Way
2.5 Intercellular Lipid Structure Pathway
2.6 Trans-cellular Pathway

3 Transdermal Patch Drug Delivery System Market Overview by Application
3.1 Global Transdermal Patch Drug Delivery System Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Transdermal Patch Drug Delivery System Historic Market Size by Application (2015-2020)
3.3 Global Transdermal Patch Drug Delivery System Forecasted Market Size by Application (2021-2026)
3.4 Hospital
3.5 Clinic
3.6 Home Care
3.7 Other

4 Global Transdermal Patch Drug Delivery System Competition Analysis by Players
4.1 Global Transdermal Patch Drug Delivery System Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Patch Drug Delivery System as of 2019)
4.3 Date of Key Manufacturers Enter into Transdermal Patch Drug Delivery System Market
4.4 Global Top Players Transdermal Patch Drug Delivery System Headquarters and Area Served
4.5 Key Players Transdermal Patch Drug Delivery System Product Solution and Service
4.6 Competitive Status
4.6.1 Transdermal Patch Drug Delivery System Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data
5.1 Hisamitsu Pharmaceutical
5.1.1 Hisamitsu Pharmaceutical Profile
5.1.2 Hisamitsu Pharmaceutical Main Business and Company’s Total Revenue
5.1.3 Hisamitsu Pharmaceutical Products, Services and Solutions
5.1.4 Hisamitsu Pharmaceutical Revenue (US$ Million) (2015-2020)
5.1.5 Hisamitsu Pharmaceutical Recent Development and Reaction to Covid-19
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business and Company’s Total Revenue
5.2.3 Novartis Products, Services and Solutions
5.2.4 Novartis Revenue (US$ Million) (2015-2020)
5.2.5 Novartis Recent Development and Reaction to Covid-19
5.3 ProSolus
5.5.1 ProSolus Profile
5.3.2 ProSolus Main Business and Company’s Total Revenue
5.3.3 ProSolus Products, Services and Solutions
5.3.4 ProSolus Revenue (US$ Million) (2015-2020)
5.3.5 Tapemark Recent Development and Reaction to Covid-19
5.4 Tapemark
5.4.1 Tapemark Profile
5.4.2 Tapemark Main Business and Company’s Total Revenue
5.4.3 Tapemark Products, Services and Solutions
5.4.4 Tapemark Revenue (US$ Million) (2015-2020)
5.4.5 Tapemark Recent Development and Reaction to Covid-19
5.5 Tesa Labtec
5.5.1 Tesa Labtec Profile
5.5.2 Tesa Labtec Main Business and Company’s Total Revenue
5.5.3 Tesa Labtec Products, Services and Solutions
5.5.4 Tesa Labtec Revenue (US$ Million) (2015-2020)
5.5.5 Tesa Labtec Recent Development and Reaction to Covid-19
5.6 NITTO DENKO CORPORATION
5.6.1 NITTO DENKO CORPORATION Profile
5.6.2 NITTO DENKO CORPORATION Main Business and Company’s Total Revenue
5.6.3 NITTO DENKO CORPORATION Products, Services and Solutions
5.6.4 NITTO DENKO CORPORATION Revenue (US$ Million) (2015-2020)
5.6.5 NITTO DENKO CORPORATION Recent Development and Reaction to Covid-19
5.7 Noven Pharmaceuticals
5.7.1 Noven Pharmaceuticals Profile
5.7.2 Noven Pharmaceuticals Main Business and Company’s Total Revenue
5.7.3 Noven Pharmaceuticals Products, Services and Solutions
5.7.4 Noven Pharmaceuticals Revenue (US$ Million) (2015-2020)
5.7.5 Noven Pharmaceuticals Recent Development and Reaction to Covid-19
5.8 LTS Lohmann Therapie-Systeme
5.8.1 LTS Lohmann Therapie-Systeme Profile
5.8.2 LTS Lohmann Therapie-Systeme Main Business and Company’s Total Revenue
5.8.3 LTS Lohmann Therapie-Systeme Products, Services and Solutions
5.8.4 LTS Lohmann Therapie-Systeme Revenue (US$ Million) (2015-2020)
5.8.5 LTS Lohmann Therapie-Systeme Recent Development and Reaction to Covid-19
5.9 Medherant
5.9.1 Medherant Profile
5.9.2 Medherant Main Business and Company’s Total Revenue
5.9.3 Medherant Products, Services and Solutions
5.9.4 Medherant Revenue (US$ Million) (2015-2020)
5.9.5 Medherant Recent Development and Reaction to Covid-19
5.10 Corium
5.10.1 Corium Profile
5.10.2 Corium Main Business and Company’s Total Revenue
5.10.3 Corium Products, Services and Solutions
5.10.4 Corium Revenue (US$ Million) (2015-2020)
5.10.5 Corium Recent Development and Reaction to Covid-19
5.11 Antares Pharma
5.11.1 Antares Pharma Profile
5.11.2 Antares Pharma Main Business and Company’s Total Revenue
5.11.3 Antares Pharma Products, Services and Solutions
5.11.4 Antares Pharma Revenue (US$ Million) (2015-2020)
5.11.5 Antares Pharma Recent Development and Reaction to Covid-19
5.12 Syntropharma
5.12.1 Syntropharma Profile
5.12.2 Syntropharma Main Business and Company’s Total Revenue
5.12.3 Syntropharma Products, Services and Solutions
5.12.4 Syntropharma Revenue (US$ Million) (2015-2020)
5.12.5 Syntropharma Recent Development and Reaction to Covid-19
5.13 Teikoku Pharma
5.13.1 Teikoku Pharma Profile
5.13.2 Teikoku Pharma Main Business and Company’s Total Revenue
5.13.3 Teikoku Pharma Products, Services and Solutions
5.13.4 Teikoku Pharma Revenue (US$ Million) (2015-2020)
5.13.5 Teikoku Pharma Recent Development and Reaction to Covid-19
5.14 Mylan
5.14.1 Mylan Profile
5.14.2 Mylan Main Business and Company’s Total Revenue
5.14.3 Mylan Products, Services and Solutions
5.14.4 Mylan Revenue (US$ Million) (2015-2020)
5.14.5 Mylan Recent Development and Reaction to Covid-19
5.15 Actavis
5.15.1 Actavis Profile
5.15.2 Actavis Main Business and Company’s Total Revenue
5.15.3 Actavis Products, Services and Solutions
5.15.4 Actavis Revenue (US$ Million) (2015-2020)
5.15.5 Actavis Recent Development and Reaction to Covid-19
5.16 Mundipharma
5.16.1 Mundipharma Profile
5.16.2 Mundipharma Main Business and Company’s Total Revenue
5.16.3 Mundipharma Products, Services and Solutions
5.16.4 Mundipharma Revenue (US$ Million) (2015-2020)
5.16.5 Mundipharma Recent Development and Reaction to Covid-19
5.17 Henan Lingrui Pharmaceutical
5.17.1 Henan Lingrui Pharmaceutical Profile
5.17.2 Henan Lingrui Pharmaceutical Main Business and Company’s Total Revenue
5.17.3 Henan Lingrui Pharmaceutical Products, Services and Solutions
5.17.4 Henan Lingrui Pharmaceutical Revenue (US$ Million) (2015-2020)
5.17.5 Henan Lingrui Pharmaceutical Recent Development and Reaction to Covid-19
5.18 Changzhou Siyao
5.18.1 Changzhou Siyao Profile
5.18.2 Changzhou Siyao Main Business and Company’s Total Revenue
5.18.3 Changzhou Siyao Products, Services and Solutions
5.18.4 Changzhou Siyao Revenue (US$ Million) (2015-2020)
5.18.5 Changzhou Siyao Recent Development and Reaction to Covid-19
5.19 Rfl Pharmaceutical
5.19.1 Rfl Pharmaceutical Profile
5.19.2 Rfl Pharmaceutical Main Business and Company’s Total Revenue
5.19.3 Rfl Pharmaceutical Products, Services and Solutions
5.19.4 Rfl Pharmaceutical Revenue (US$ Million) (2015-2020)
5.19.5 Rfl Pharmaceutical Recent Development and Reaction to Covid-19

6 North America Transdermal Patch Drug Delivery System by Players and by Application
6.1 North America Transdermal Patch Drug Delivery System Market Size and Market Share by Players (2015-2020)
6.2 North America Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)

7 Europe Transdermal Patch Drug Delivery System by Players and by Application
7.1 Europe Transdermal Patch Drug Delivery System Market Size and Market Share by Players (2015-2020)
7.2 Europe Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)

8 China Transdermal Patch Drug Delivery System by Players and by Application
8.1 China Transdermal Patch Drug Delivery System Market Size and Market Share by Players (2015-2020)
8.2 China Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)

9 Rest of Asia Pacific Transdermal Patch Drug Delivery System by Players and by Application
9.1 Rest of Asia Pacific Transdermal Patch Drug Delivery System Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)

10 Latin America Transdermal Patch Drug Delivery System by Players and by Application
10.1 Latin America Transdermal Patch Drug Delivery System Market Size and Market Share by Players (2015-2020)
10.2 Latin America Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)

11 Middle East & Africa Transdermal Patch Drug Delivery System by Players and by Application
11.1 Middle East & Africa Transdermal Patch Drug Delivery System Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Application (2015-2020)

12 Transdermal Patch Drug Delivery System Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis

13 Research Finding /Conclusion

14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
  • FORMAT: PDF
  • PUBLISHED DATE: Nov, 2020
  • NO OF PAGES: 125